B2M, beta-2-microglobulin, 567

N. diseases: 352; N. variants: 6
Disease: Hemodialysis-associated amyloidosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0268405
Disease: Hemodialysis-associated amyloidosis
Hemodialysis-associated amyloidosis 		0.050 Biomarker disease BEFREE β2-microglobulin-related (Aβ2M) amyloidosis (dialysis-associated amyloidosis) is a common complication in long-term dialysis patients. 30707483 2019
CUI: C0268405
Disease: Hemodialysis-associated amyloidosis
Hemodialysis-associated amyloidosis 		0.050 GeneticVariation disease BEFREE Beta 2-microglobulin amyloidosis (A beta 2m) is a serious complication for patients undergoing long-term dialysis. beta 2-microglobulin modified with advanced glycation end products (beta 2m-AGE) is a major component of the amyloid in A beta 2m. 9573554 1998
CUI: C0268405
Disease: Hemodialysis-associated amyloidosis
Hemodialysis-associated amyloidosis 		0.050 Biomarker disease BEFREE The primary structure of beta 2-microglobulin (beta 2m), the major constituent protein of beta 2-microglobulin amyloidosis (A beta 2m) or dialysis-amyloidosis, was initially shown to be identical to serum beta 2m, thereby strongly suggesting the polymerization of intact beta 2m in tissues. 8887286 1996
CUI: C0268405
Disease: Hemodialysis-associated amyloidosis
Hemodialysis-associated amyloidosis 		0.050 Biomarker disease BEFREE Beta 2-microglobulin (beta 2M) is responsible for dialysis-associated amyloidosis. 8785408 1996
CUI: C0268405
Disease: Hemodialysis-associated amyloidosis
Hemodialysis-associated amyloidosis 		0.050 Biomarker disease BEFREE Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites. 7918443 1994